First ever drug approved for NHS patients with life-threatening genetic, tumour-causing disease

NHS patients in England with a rare genetic disease that causes tumours in major organs, including the brain and spine, can now benefit from the first-ever therapy which could shrink their tumours to help them avoid high-risk surgery. In clinical trials of belzutifan, 95% of patients did not experience any growth in their tumours in […]

Read More  on the NHS website.